rated new Buy at Wunderlich. $20 price target. Company is leveraged to higher demand for land drilling and pressure pumping.
downgraded at Jefferies to Hold from Buy, Jefferies said. $30 price target. Aetna policy change is explicit.
rated new Above Average at Caris & Company. $55 price target. Core brand can deliver double-digit annual growth.
upgraded at Compass Point from Market Perform to Buy, Compass Point said. Company can outperform its peers in the midst of an industry recovery.
downgraded at Mizuho to Neutral, Mizuho said. $45 price target. Company may lose market share in the coming quarters.
(X - Get Report)
downgraded at Nomura from Buy to Neutral, Nomura said. $20 price target. Earnings power will be hurt by lower bulk material prices.
STOCK COMMENTS / EPS CHANGES
estimates reduced at JMP through 2013, JMP Securities said. Company guided toward lower expected sales. Underperform rating and $26 price target.
Bed Bath & Beyond
numbers trimmed at UBS. Shares of BBBY now seen reaching $71, UBS said. Estimates also lowered on significant GM contraction in 2Q. Neutral rating.
numbers increased at ThinkEquity. CRM estimates were raised through 2014, ThinkEquity said. Company reiterated solid demand momentum at its user conference. Outperform rating and new $190 price target.
Salesforce.com numbers raised at Jefferies. Shares of CRM now seen reaching $180, Jefferies said. Estimates also raised on larger TAM and faster innovation. Buy rating.
numbers raised at Sterne Agee. Shares of CRUS now seen reaching $55, according to Sterne Agee. Estimates also increased, as the company appears to be receiving more revenue per mobile device. Buy rating.
estimates, target boosted at BMO. Shares of EMC now seen reaching $31, according to BMO Capital. Estimates also upped, as the company can continue to gain market share in the near term. Outperform rating.
numbers cut at Credit Suisse. NSC estimates were reduced through 2014, Credit Suisse said. Company lowered its guidance. Outperform rating and new $87 price target.
estimates, target boosted at Keybanc. Shares of PII now seen reaching $90, according to Keybanc. Estimates also upped, following solid industry channel checks. Buy rating.